MYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION Trademark

Trademark Overview


On Friday, December 15, 2000, a trademark application was filed for MYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION with the United States Patent and Trademark Office. The USPTO has given the MYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION trademark a serial number of 78039531. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, May 30, 2009. This trademark is owned by Elan Pharmaceuticals, Inc.. The MYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
myobloc botulinum toxin type b injectable solution

General Information


Serial Number78039531
Word MarkMYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION
Filing DateFriday, December 15, 2000
Status710 - CANCELLED - SECTION 8
Status DateSaturday, May 30, 2009
Registration Number2639583
Registration DateTuesday, October 22, 2002
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 30, 2002

Trademark Statements


Disclaimer with Predetermined Text"BOTULINUM TOXIN TYPE B" and "INJECTABLE SOLUTION"
Description of MarkThe mark consists of a check and a circle together with the words "MYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION".
Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, May 30, 2009
Primary Code005
First Use Anywhere DateWednesday, December 27, 2000
First Use In Commerce DateWednesday, December 27, 2000

Trademark Owner History


Party NameSOLSTICE NEUROSCIENCES, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMALVERN, PA 19355

Party NameElan Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameElan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameElan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Wednesday, August 18, 2010ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, May 30, 2009CANCELLED SEC. 8 (6-YR)
Thursday, November 29, 2007CASE FILE IN TICRS
Tuesday, May 17, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 22, 2002REGISTERED-PRINCIPAL REGISTER
Tuesday, July 30, 2002PUBLISHED FOR OPPOSITION
Wednesday, July 10, 2002NOTICE OF PUBLICATION
Saturday, June 1, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 24, 2002PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, May 22, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2002EXAMINERS AMENDMENT E-MAILED
Wednesday, May 22, 2002USE AMENDMENT ACCEPTED
Tuesday, March 5, 2002AMENDMENT TO USE PROCESSING COMPLETE
Friday, December 7, 2001USE AMENDMENT FILED
Friday, December 7, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 8, 2001NON-FINAL ACTION MAILED
Thursday, May 10, 2001ASSIGNED TO EXAMINER